VR Logo

Alembic Pharmaceuticals: Announcement under Regulation 30 (LODR)-Press Release / Media Release


With reference to the captioned subject this is to inform the exchange that the Companys joint venture Aleor Dermaceuticals Limited has received US Food and Drug Administration (USFDA) Final Approval for Tavaborole Topical Solution 5%.

Please find enclosed herewith our press release.

We request you to kindly take the same on record.

Click here to view PDF